New Horizon Biotech is at the forefront of advancing diagnostics and personalized medicine through cutting-edge genomics and AI-driven solutions. Our mission is to empower healthcare providers with the tools and insights needed to deliver precise, effective care. We specialize in rare and inherited disease diagnostics, offering a complete end-to-end solution. From sample collection to advanced whole exome sequencing (WES) or whole genome sequencing (WGS), we utilize a proprietary, high-quality bioinformatics pipeline. Our team of medical geneticists, bioinformaticians, and AI experts work together to provide actionable insights that address complex genetic conditions.

In addition to rare disease diagnostics, we are proud to introduce our pharmacogenetics service. This innovative solution focuses on analyzing several hundred genes to identify the best treatment options for cancer patients. By leveraging comprehensive genomic data and advanced algorithms, we provide clinicians with tailored insights that optimize therapeutic decisions, ensuring the most effective and personalized cancer care.

New Horizon Biotech is committed to harnessing the power of technology and science to improve patient outcomes. We are also exploring multi-modal data integration and population studies to further our understanding of complex health conditions and enhance personalized medicine. With a multidisciplinary team and a focus on innovation, we are shaping the future of genomics-driven healthcare.